Terlipressin
From Wikipedia, the free encyclopedia
Image:Terlipressin.png | |
Terlipressin
|
|
Systematic (IUPAC) name | |
? | |
Identifiers | |
CAS number | ? |
ATC code | H01BA04 |
PubChem | 72081 |
DrugBank | EXPT03310 |
Chemical data | |
Formula | C52H74N16O15S2 |
Mol. weight | 1227.37 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Protein binding | ~30% |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | IV |
Terlipressin as vasoactive drug used for the management of hypotension. It has been found to be effective when norepinephrine does not help.
Indications for use include norepinephrine-resistant septic shock and hepatorenal syndrome. In addition, it is used in bleeding esophageal varices .
[edit] See also
[edit] References
- ↑ O'Brien A, Clapp L, Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet. 2002 Apr 6;359(9313):1209-10. PMID 11955542.
- ↑ Uriz J, Gines P, Cardenas A, Sort P, Jimenez W, Salmeron JM, Bataller R, Mas A, Navasa M, Arroyo V, Rodes J. Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. J Hepatol. 2000 Jul;33(1):43-8. Full Text. PMID 10905585.
- ↑ Ioannou G, Doust J, Rockey DC. Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database Syst Rev 2003;(1):CD002147. PMID 12535432.